TELIX Pharmaceuticals Ltd (TLX) — Free Cash Flow Generation Index
TELIX Pharmaceuticals Ltd (TLX) has a Free Cash Flow Generation Index of 0.60x as of June 2025. Free cash flow of AU$16.84 Million represents 1% of operating cash flow (AU$27.98 Million). See TLX working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
TELIX Pharmaceuticals Ltd Free Cash Flow Generation Index (2020–2024)
Historical FCF Generation Index trend for TELIX Pharmaceuticals Ltd across 3 annual periods. Explore TLX cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for TELIX Pharmaceuticals Ltd (2020–2024)
Year-by-year Free Cash Flow Generation Index for TELIX Pharmaceuticals Ltd. For the full company profile including market capitalisation, see market cap of TELIX Pharmaceuticals Ltd.
| Year | FCG Index | Free Cash Flow (AUD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.21x | AU$9.00 Million | AU$43.03 Million | AU$34.03 Million | ▼ -61.8% |
| 2023 | 0.55x | AU$13.09 Million | AU$23.88 Million | AU$10.79 Million | ▼ -34.4% |
| 2020 | 0.84x | AU$1.64 Million | AU$1.96 Million | AU$322.00K | — |